Skip to main content
FinSpry Logo
FinSpry
ABBV logo
ABBV
(NYSE)
AbbVie Inc.
$253.30-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

AbbVie (ABBV) Stock Price & Financial Analysis

AbbVie Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$252.25 - $257.81
52-Week High$261.64
52-Week Low$184.63
Open$257.81
Volume4.79M
Average Volume (3M)7.95M
Market Cap455.78B
Shares Outstanding1.77B
P/E Ratio (TTM)124.15
Forward P/E143.18
Price to Sales (P/S)7.18
Price to Book (P/B)16.41
EV/EBITDA25.39
Revenue (TTM)62.82B
Net Income (TTM)3.63B
Free Cash Flow (TTM)19.98B
EPS (TTM)$2.05
Profit Margin5.79%
Operating Margin26.42%
Return on Equity (ROE)13.22%
Debt to Equity2.65
50-Day MA$228.11
200-Day MA$223.50
52-Week Change32.91%
Annual Dividend$6.83
Dividend Yield2.68%
Payout Ratio200.00%
Last Dividend Ex-DateJul 15, 2026

Frequently Asked Questions About AbbVie

What is the current stock price for ABBV?

As of the latest trading session, ABBV stock trades at $253.30. The 52-week range is $184.63–$261.64, with a day range of $252.25–$257.81.

What is the P/E ratio for ABBV?

AbbVie's trailing P/E ratio is 124.2, meaning investors pay $124.2 for every $1 of annual earnings. The forward P/E is 143.2, reflecting analyst expectations for future earnings. AbbVie operates in the Healthcare sector.

Does ABBV pay dividends?

Yes, AbbVie pays a 2.68% annual dividend yield ($6.83 per share). The payout ratio is 200.0%. The last ex-dividend date was 2026-07-15.

What do analysts recommend for ABBV?

Based on 31 analysts, the consensus for ABBV is Buy.

What is the market cap of ABBV?

AbbVie's market capitalization is $449.35B, classifying it as a mega-cap company. AbbVie operates in the Healthcare sector within the Drug Manufacturers - General industry.